Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-26

Clinical Trial Update: A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of a new treatment for macular edema due to retinal vein occlusion has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • A new treatment (unnamed in snippet)

Snippet

Sponsor: Allergan | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 3 | Status: COMPLETED | Results posted: 2009-08-26